GlassScriptPhysician profile
Lindsey Bernard
NPI 1326746538
$732.51
in general payments reported to CMS, 2019-2025
10 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $351 · 2024: $228 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.81 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $129.32 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $127.99 | 2023-2024 | Myfembree |
| Ascend Therapeutics US, LLC | $102.95 | 2023 | |
| Astellas Pharma US INC | $102.91 | 2024 | Veozah |
| Exeltis, USA INC. | $94.93 | 2023-2025 | Slynd |
| Abbvie INC. | $48.33 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.56 | 2023 | |
| Mayne Pharma Commercial LLC | $33.04 | 2025 | |
| Sage Therapeutics, LLC | $31.32 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $28.16 | 2024 | Myosure Tissue Removal Device, Omni Hysteroscope, Novasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.